Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital

被引:90
作者
Lim, JA
Kwon, AR
Kim, SK
Chong, YS
Lee, K
Choi, EC [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[2] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul 151742, South Korea
[3] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea
[4] Yonsei Univ, Coll Med, Dept Clin Pathol, Seoul, South Korea
关键词
D O I
10.1093/jac/49.3.489
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To investigate the prevalence of resistance to macrolide, lincosamide and streptogramin (MLS) antibiotics in Gram-positive cocci isolated in a Korean hospital, we tested the antibiotic susceptibility of 1097 clinical isolates of Staphylococcus aureus, coagulase-negative staphylococci (CNS) and enterococci to the macrolides erythromycin, clarithromycin, azithromycin and josamycin, the lincosamide clindamycin and the streptogramin pristinamycin. These three groups of organisms were mostly resistant to macrolides and lincosamide, but were commonly susceptible to pristinamycin. The resistance phenotypes of erythromycin-resistant isolates were determined by the double-disc test with erythromycin and clindamycin, which showed that most exhibited constitutive MLS resistance. In order to determine the prevalence of the resistance genotypes and the resistance mechanisms, the presence of the erm(A), erm(B), erm(C) and mef genes in the erythromycin-resistant isolates was identified by PCR analysis. The resistance was due mainly to the presence of erm(A) in S. aureus (82.5%), erm(B) in enterococci (55%) and erm(C) in CNS (47.2%).
引用
收藏
页码:489 / 495
页数:7
相关论文
共 37 条
[1]  
ALLIGNET J, 1992, GENE, V117, P47
[2]   Presence of mefA and mefE genes in Streptococcus agalactiae [J].
Arpin, C ;
Daube, H ;
Tessier, F ;
Quentin, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) :944-946
[3]   NUCLEOTIDE-SEQUENCE OF GENE LINA ENCODING RESISTANCE TO LINCOSAMIDES IN STAPHYLOCOCCUS-HAEMOLYTICUS [J].
BRISSONNOEL, A ;
COURVALIN, P .
GENE, 1986, 43 (03) :247-253
[4]   Macrolides resistance of common bacteria isolated from Taiwan [J].
Chang, SC ;
Chen, YC ;
Luh, KT ;
Hsieh, WC .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 23 (04) :147-154
[5]   Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes [J].
Clancy, J ;
Petitpas, J ;
DibHajj, F ;
Yuan, W ;
Cronan, M ;
Kamath, AV ;
Bergeron, J ;
Retsema, JA .
MOLECULAR MICROBIOLOGY, 1996, 22 (05) :867-879
[6]  
Comite de l'Antibiogramme de la Societe Francaise de Microbiologie, 1996, CLIN MICROBIOL INFEC, V2, P46
[7]   In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae [J].
Davies, TA ;
Dewasse, BE ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :414-417
[8]   EVOLUTION AND EPIDEMIOLOGY OF MLS RESISTANCE [J].
DUVAL, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 :137-149
[9]   DISTRIBUTION OF GENES ENCODING ERYTHROMYCIN RIBOSOMAL METHYLASES AND AN ERYTHROMYCIN EFFLUX PUMP IN EPIDEMIOLOGICALLY DISTINCT GROUPS OF STAPHYLOCOCCI [J].
EADY, EA ;
ROSS, JI ;
TIPPER, JL ;
WALTERS, CE ;
COVE, JH ;
NOBLE, WC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (02) :211-217
[10]   Macrolide resistance in Streptococcus pneumoniae in Hong Kong [J].
Ip, M ;
Lyon, DJ ;
Yung, RWH ;
Chan, C ;
Cheng, AFB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (05) :1578-1580